source
- Trump threatens up to 200% tariffs on generic drugs not manufactured in the United StatesPresident Donald Trump announced that his administration will consider imposing steep tariffs on generic medicines that are imported rather than produced in the United States. The proposed tariffs…
- Mentari Therapeutics secures second $200M private placement to fund migraine program and advance reverse mergerMentari Therapeutics, a spin‑out focused on migraine treatments, announced it has arranged a second private‑placement financing of $200 million. The new capital will be used to advance its migrain…